The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of isunakinra, an IL-1 alfa/beta inhibitor, in combination with nivolumab for patients with solid tumors refractory to standard therapies.
 
Carlos Roberto Becerra
Consulting or Advisory Role - Ipsen; Legend Biotech
 
Andrew Scott Paulson
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Alexion Pharmaceuticals; Aptose Biosciences; Lynx Health; Stromatis Pharma
Honoraria - Cardinal Health
Consulting or Advisory Role - AADi; Advanced Accelerator Applications; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Eisai; EMD Serono; EMD Serono; Exelixis; Exelixis; Exelixis; Hutchison MediPharma; Incyte; Ipsen; Lilly; Mirati Therapeutics; Pfizer; QED Therapeutics; SERVIER; Stromatis Pharma
Speakers' Bureau - Ideo Oncology
Research Funding - AstraZeneca (Inst); Bayer (Inst); BioNTech SE (Inst); bristol myers squibb (Inst); Camurus (Inst); Camurus (Inst); Deciphera (Inst); Exelixis (Inst); G1 Therapeutics (Inst); Gilead Sciences (Inst); Gritstone Bio (Inst); Hutchison MediPharma (Inst); incyte (Inst); Innovative Cellular Therapeutics Co (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Nucana (Inst); Regenxbio (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sotio (Inst); Taiho Pharmaceutical (Inst); Tempus (Inst); Zentalis (Inst)
Travel, Accommodations, Expenses - Camurus; Pfizer
 
Jan Kowalski
Consulting or Advisory Role - Buzzard Pharmaceuticals
Travel, Accommodations, Expenses - Buzzard Pharmaceuticals
 
Hans Olivecrona
Leadership - Buzzard Pharmaceuticals
Stock and Other Ownership Interests - Buzzard Pharmaceuticals
Consulting or Advisory Role - Buzzard Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Buzzard Pharmaceuticals
Expert Testimony - Klaria Pharma
Travel, Accommodations, Expenses - Buzzard Pharmaceuticals
 
Maarten de Chateau
Employment - Buzzard Pharmaceuticals; Sixera Pharma
Leadership - Beactica; Buzzard Pharmaceuticals; Sixera Pharma; Xintela
Stock and Other Ownership Interests - Beactica; Buzzard Pharmaceuticals; Sixera Pharma; Xintela
Consulting or Advisory Role - Linc
Patents, Royalties, Other Intellectual Property - Buzzard Pharmaceuticals